Southwest Oncology Group study of mitoxa
โ
Douglas E. Mattox; Daniel D. Hoff; Stanley P. Balcerzak
๐
Article
๐
1990
๐
Springer US
๐
English
โ 170 KB
Eighteen patients are evaluable for response in a Phase II trial of Mitoxantrone for advanced adenoid cystic carcinoma of the head and neck. One patient had a complete response; there were no partial responses. Twelve patients had stable disease for 3 or more months. There was no significant anti-tu